Kontakt

Wiodące firmy CDMO w Europie

Twoi zaufani europejscy partnerzy w zakresie produkcji kontraktowej i rozwoju

Zastosowane filtry:Europa×Wyczyść wszystko
Seans 130 udogodnienia
SENN Chemicals | R&D and Kilo Lab | Dielsdorf, Switzerland
Szwajcaria

SENN Chemicals | R&D and Kilo Lab | Dielsdorf, Switzerland

Senn Chemicals

Szwajcarski ośrodek badawczo-rozwojowy dotyczący peptydów i półproduktów peptydowych obejmujący SPPS, LPPS, syntezę hybrydową, zwiększanie skali laboratoryjnej

USŁUGI: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europa

KATEGORIA / PRODUKT: KOSMETYKI, CHEMICZNO-SYNTETYCZNY, USŁUGI, INŻYNIERIA CZĄSTEK

ROZMIAR PARTII: Small

SENN Chemicals | Small Scale GMP Lab | Dielsdorf, Switzerland
Szwajcaria

SENN Chemicals | Small Scale GMP Lab | Dielsdorf, Switzerland

Senn Chemicals

Laboratorium peptydów GMP i syntezy organicznej na małą skalę do projektów klinicznych, niszowych i o wysokiej wartości, wymagających elastycznej produkcji cGMP

USŁUGI: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europa

KATEGORIA / PRODUKT: CHEMICZNO-SYNTETYCZNY, INŻYNIERIA CZĄSTEK

ROZMIAR PARTII: Small

SENN Chemicals | GMP Production | Dielsdorf, Switzerland
Szwajcaria

SENN Chemicals | GMP Production | Dielsdorf, Switzerland

Senn Chemicals

Szwajcarski zakład produkcyjny cGMP do produkcji LPPS, SPPS i peptydów hybrydowych od pilotażu do wczesnej skali komercyjnej.

USŁUGI: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europa

ROZMIAR PARTII: Large, Medium

KATEGORIA / PRODUKT: CHEMICZNO-SYNTETYCZNY, INŻYNIERIA CZĄSTEK

Laboratorio REIG JOFRE, SA (TOLEDO PLANT)
Hiszpania

Laboratorio REIG JOFRE, SA (TOLEDO PLANT)

LABORATORIO REIG JOFRE SA

Rozwój i produkcja antybiotyków betalaktamowych (FDF) w najnowocześniejszych zakładach.

RYNKI: EMA (EU), ANVISA (Brazil), ISP (Chile), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), INVIMA (Colombia), SFDA (Saudi Arabia), TGA (Australia)

REGION: APAC, MENA, LATAM, Europa, Ameryka Północna

ZGODNOŚĆ: DIGEMID, ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), ECOVADIS, TGA (Australia GMP), UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority), INVIMA, ISP (Chile BPM), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)

ROZMIAR PARTII: Large, Medium

UŻYWAĆ: Human, Veterinary

BSL (poziom bezpieczeństwa biologicznego): 1

USŁUGI: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

TERAPEUTYCZNE OBSZARY WIEDZY (ATC): (J) Antiinfectives for systemic use

SUBSTANCJE KONTROLOWANE: Lowest potential for abuse

OEB (pasmo narażenia zawodowego): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

KATEGORIA / PRODUKT: FDF / PRODUKTY LEKOWE

Laboratorios Grifols | Barcelona Plant
Hiszpania

Laboratorios Grifols | Barcelona Plant

Grifols International

Sterylne roztwory produkcyjne (małe cząsteczki) w elastycznych workach i fiolkach.

RYNKI: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), ANMAT (Argentina), MFDS (South Korea), TGA (Australia)

USŁUGI: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europa

ZGODNOŚĆ: FDA (cGMP), ISO, ANVISA (Brazil B-GMP), ECOVADIS, TGA (Australia GMP), INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

ROZMIAR PARTII: Large, Small, Medium

UŻYWAĆ: Human, Veterinary

TERAPEUTYCZNE OBSZARY WIEDZY (ATC): (C) Cardiovascular system, (M) Musculoskeletal system, (N) Nervous system, (A) Digestive tract and metabolism

SUBSTANCJE KONTROLOWANE: Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

OEB (pasmo narażenia zawodowego): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

KATEGORIA / PRODUKT: FDF / PRODUKTY LEKOWE

White Raven - Legiapark
Belgia

White Raven - Legiapark

White Raven

Miejsce napełniania i wykańczania poświęcone formułowaniu GMP i aseptycznemu napełnianiu sterylnych płynnych wstrzykiwaczy.

OEB (pasmo narażenia zawodowego): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

RYNKI: EMA (EU)

REGION: Europa

UŻYWAĆ: Human

BSL (poziom bezpieczeństwa biologicznego): 1, 2

USŁUGI: Manufacturing services, Packaging

ROZMIAR PARTII: Small, Medium

ZGODNOŚĆ: EMA (EU GMP)

KATEGORIA / PRODUKT: BIOLOGIA, FDF / PRODUKTY LEKOWE

Laboratorio REIG JOFRE, SA (BARCELONA PLANT)
Hiszpania

Laboratorio REIG JOFRE, SA (BARCELONA PLANT)

LABORATORIO REIG JOFRE SA

Zakłady produkujące produkty do wstrzykiwania (lyo i płyn) oraz płynne.

BSL (poziom bezpieczeństwa biologicznego): 3, 1, 2

RYNKI: EMA (EU), PMDA (Japan), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MHRA (UK), INVIMA (Colombia), MFDS (South Korea), TGA (Australia)

REGION: Europa

ROZMIAR PARTII: Large, Medium

UŻYWAĆ: Human, Veterinary

USŁUGI: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

TERAPEUTYCZNE OBSZARY WIEDZY (ATC): (C) Cardiovascular system, (D) Dermatologicals, (J) Antiinfectives for systemic use, (N) Nervous system, (R) Respiratory system, (A) Digestive tract and metabolism

SUBSTANCJE KONTROLOWANE: Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

ZGODNOŚĆ: PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), ECOVADIS, INVIMA, ISP (Chile BPM), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

OEB (pasmo narażenia zawodowego): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

KATEGORIA / PRODUKT: FDF / PRODUKTY LEKOWE

Sylentis
Hiszpania

Sylentis

Sylentis

Producent oligonukleotydów.

ZGODNOŚĆ: ICH, FDA (cGMP), ISO, EMA (EU GMP), World Health Organization (GMP / HACCP)

RYNKI: EMA (EU), FDA (USA)

REGION: Europa

ROZMIAR PARTII: Large, Small, Medium

UŻYWAĆ: Human, Veterinary

KATEGORIA / PRODUKT: OLIGONUKLEOTYDY

USŁUGI: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services

OEB (pasmo narażenia zawodowego): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

VIVEbiotech
Hiszpania

VIVEbiotech

VIVEbiotech

Twoje wiodące CDMO z certyfikatem GMP, przeznaczone wyłącznie do produkcji wektorów lentiwirusowych.

RYNKI: EMA (EU), FDA (USA), MHRA (UK)

REGION: Europa

ZGODNOŚĆ: FDA (cGMP), French Service-Public (CIR), EMA (EU GMP), MHRA (UK GMP)

ROZMIAR PARTII: Large, Small, Medium

UŻYWAĆ: Human

BSL (poziom bezpieczeństwa biologicznego): 1, 2

USŁUGI: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

KATEGORIA / PRODUKT: BIOLOGIA

Pharmaron API Commercial Synthesis Cramlington (UK)
Wielka Brytania

Pharmaron API Commercial Synthesis Cramlington (UK)

Pharmaron

Komercyjna synteza małych cząsteczek API.

TERAPEUTYCZNE OBSZARY WIEDZY (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

SUBSTANCJE KONTROLOWANE: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse

RYNKI: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), MFDS (South Korea), TGA (Australia)

REGION: Europa

ZGODNOŚĆ: FDA (cGMP), PMDA/MHLW (Japan GMP), TGA (Australia GMP), EMA (EU GMP), Health Canada (Canada GMP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

ROZMIAR PARTII: Large, Small, Medium

UŻYWAĆ: Human, Veterinary

KATEGORIA / PRODUKT: CHEMICZNO-SYNTETYCZNY

USŁUGI: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services

OEB (pasmo narażenia zawodowego): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

HIPRA BIOTECH SERVICES | Amer
Hiszpania

HIPRA BIOTECH SERVICES | Amer

HIPRA Biotech Services

Kompleksowe możliwości wewnętrzne, od rozwoju linii komórkowych po produkcję komercyjną.

RYNKI: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia)

USŁUGI: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europa

ZGODNOŚĆ: DIGEMID, FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)

ROZMIAR PARTII: Large, Small, Medium

UŻYWAĆ: Human, Veterinary

BSL (poziom bezpieczeństwa biologicznego): 1, 2

OEB (pasmo narażenia zawodowego): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

KATEGORIA / PRODUKT: BIOLOGIA, FDF / PRODUKTY LEKOWE

BAG Health Care
Niemcy

BAG Health Care

BAG Health Care GmbH

Dostawca napojów i napojów pozajelitowych do fiolek w małych i średnich partiach.

RYNKI: EMA (EU), MHRA (UK), TGA (Australia)

REGION: Europa

UŻYWAĆ: Human, Veterinary

BSL (poziom bezpieczeństwa biologicznego): 1

USŁUGI: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

OEB (pasmo narażenia zawodowego): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

ROZMIAR PARTII: Small, Medium

ZGODNOŚĆ: EMA (EU GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)

KATEGORIA / PRODUKT: FDF / PRODUKTY LEKOWE

Więcej udogodnień w sieci

Zarejestruj się, aby odblokować pełny katalog z danymi kontaktowymi i lokalizacjami.

+55 więcej udogodnień

Utwórz darmowe konto

Europe boasts a dynamic industry of CDMO companies offering world-class pharmaceutical development and manufacturing services. Recognized for their regulatory expertise, cutting-edge technology and innovative approaches, European CDMOs play a key role in bringing high-quality drug products to global markets. Whether you are looking for small-scale production or large-scale commercial capabilities, Europe´s diverse network of CDMO pharmaceutical companies offers you unrivaled solutions tailored to your needs.

Why Choose European CDMOs?

Offering Advanced Infrastructure and Technology: European CDMOs stand out for their world-class facilities and advanced technology, ensuring high precision and quality at each manufacturing stage. Continuous investment in innovation and automation places them at the forefront of pharmaceutical production, making them reliable and efficient partners.

Providing Regulatory Expertise: Navigating complex regulations is a strength of European CDMOs. With expertise in EMA standards and compliance with global guidelines like FDA and WHO, they guarantee products that meet stringent safety and efficacy requirements.

Leveraging Strategic Geographic Advantage: Europe’s central location offers unmatched global trade access. CDMOs in Europe benefit from well-established distribution networks, ensuring timely and efficient product deliveries to key markets worldwide.

Key Services Offered by European Contract Manufacturers

Ensuring Comprehensive Quality Assurance: Quality control is at the core of European contract manufacturers. Every stage—from raw material selection to product release—is meticulously monitored to ensure consistency and reduce production risks.

Fostering Innovation-Driven Manufacturing: European CDMOs are leaders in innovation, with significant R&D investments. Their expertise in advanced processes like continuous manufacturing and green chemistry enhances efficiency and supports sustainable production practices.

Delivering Flexible and Scalable Production: Contract manufacturers in Europe offer tailored production options to fit different needs, from small clinical trial batches to full-scale commercial manufacturing. Their scalable processes allow seamless adaptation to fluctuating demands.

Advantages of Partnering with CDMOs in Europe

Delivering Unparalleled Quality and Reliability: European CDMOs are recognized globally for their stringent quality standards and reliability, ensuring product consistency and reducing time-to-market delays.

Accessing Innovation Hubs Across Europe:

  • Western Europe: Countries like Germany, France, and Switzerland lead in pharmaceutical innovation and host some of the most renowned CDMOs.
  • Northern Europe: Nordic countries prioritize sustainability and cutting-edge technology, ideal for eco-conscious pharmaceutical projects.
  • Southern and Eastern Europe: Nations like Italy, Spain, and Poland offer cost-efficient services without compromising on quality, becoming popular outsourcing destinations.

CDMO companies in Europe

Some of the top CDMO companies in Europe:

  • Sidefarma: Manufacture of small and medium-size batches for pharmaceutical companies across the world in regulated markets following European quality standards. [See CDMO profile]

  • APR LAB: Contract Service Unit of a Swiss Biopharmaceutical Company that identifies, develops, and markets novel products in rare and ultra-rare diseases globally. [See CDMO profile]

  • Unither Pharmaceuticals: Develops and manufactures affordable healthcare solutions designed to improve and simplify patients’ lives. [See CDMO profile]

  • CZ Vaccines: Specializes in the manufacturing of injectables, biologics, antibodies (Abs), peptides, and related products. [See CDMO profile]

  • Adragos Pharma: Manufactures semi-solid and non-sterile liquid pharmaceuticals, sterile liquids, and suppositories. The company handles over 100 molecules and offers stability studies, narcotics handling, and analytical testing services. [See CDMO profile]

  • Adare Pharma: Provides turnkey product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical, Animal Health, and OTC markets. [See CDMO profile]

  • BAG Health Care: Parenteral fill-and-finish provider for vials in small to mid-sized batches. [See CDMO profile]

  • Basic Pharma Manufacturing: Supports the transition of pharmaceuticals from lab scale to early clinical phase and beyond with GMP-compliant clean rooms and advanced equipment. [See CDMO profile]

  • Rodon Biologics: Provides excellence in the development and GMP manufacturing of biopharmaceutical products for third parties. [See CDMO profile]

  • Lukas Heil-Betriebsstätte: Operates a high-performance GMP-compliant production facility for sterile and aseptic liquids, particularly glass ampoules. [See CDMO profile]

  • Sylentis: Specialized oligonucleotide manufacturer offering integrated R&D and production capabilities. [See CDMO profile]

  • AdhexPharma SAS: CDMO specializing in the development and manufacturing of transdermal patches and oromucosal films. [See CDMO profile]

  • MENADIONA S.L: Spanish manufacturer of APIs, intermediates, and fine chemicals specialized in transferring R&D projects into fully cGMP-compliant manufacturing processes. [See CDMO profile]

  • CARBOGEN AMCIS: Provides comprehensive drug development and commercialization services to the pharmaceutical and biopharmaceutical industries at all stages of development. [See CDMO profile]

  • Rioja Nature Pharma: CDMO specialized in nutraceutical and food supplement development and manufacturing. [See CDMO profile]

  • i+Med: Developer and manufacturer of innovative drug products featuring controlled release technologies. [See CDMO profile]

  • Cultiply: Spanish CDMO focused on developing production and purification processes for recombinant proteins, enzymes, DNA, and other bioderived products. [See CDMO profile]

  • BDI biotech Production Plant: Acts as an R&D department specialized in strain and bioprocess development, scale-up, and batch production. [See CDMO profile]

  • Aenova: In Europe and worldwide, Aenova is one of the leading contract development and manufacturing organisations (CDMO). [See CDMO profile]

  • Grifols International: Injectables manufacturing. [See CMO profile]

  • CDM Lavoisier: European CDMO specialized in the manufacturing of glass ampoules, glass vials, and plastic (BFS) ampoules. [See CDMO profile]

  • ChemCon: Contract development and manufacturing partner in Europe for APIs and fine chemicals, specialized in transferring R&D projects into fully cGMP-compliant manufacturing processes. [See CDMO profile]

  • Mabion: Fully integrated European CDMO offering services for the development and GMP manufacturing of biotherapeutics, including monoclonal antibodies and recombinant protein-based products. [See CDMO profile]

  • Pharmaloop (a Salvat Company): Fully integrated CDMO solutions in Europe for Blow-Fill-Seal (BFS), sterile multidose, non-sterile multidose, sachets, capsules, and tablets. [See CDMO profile]

  • Cenexi: European CDMO specialized in the manufacture and filling of injectable and non-injectable sterile liquid products. [See CDMO profile]

  • Reig Jofre: Contract pharmaceutical development and manufacturing services in Europe for finished dosage forms (FDF): sterile liquids, lyophilizates, non-sterile liquids, and betalactam antibiotics. [See CDMO profile]

  • FAES FARMA: European developer and manufacturer of human medicinal products. [See CDMO profile]

  • Liof Pharma: Reliable CDMO partner in Europe for aseptic manufacturing and lyophilization of biologics and injectable drugs. [See CDMO profile]

  • Histocell: European CDMO that develops cell therapies from iPSCs, MSCs, secretomes, exosomes, and other cell types, as well as medical devices and dermocosmetic products. [See CDMO profile]

  • VIVEbiotech: Leading GMP-certified CDMO exclusively dedicated to the production of lentiviral vectors. [See CDMO profile]

  • 53Biologics: European CDMO specialized in biologics production, from DNA to proteins, providing services from preclinical to cGMP manufacturing. [See CDMO profile]

  • Pharmaron: Small molecule (RSM/APIs) manufacturing facility in Europe. [See CDMO profile]

  • VIVUNT PHARMA: CMO in Europe for sterile oncology drugs. Liquid and lyophilized vials fully compliant with EU GMP Annex 1. [See CMO profile]

  • Ascil Biopharm: GMP facility equipped for R&D and pharmaceutical development, including laboratories and pilot plant for sterile product batches. [See CDMO profile]

  • Laboratori Alchemia: High-quality APIs for the pharmaceutical industry. [See CDMO profile]

  • Skyepharma: Fully integrated European CDMO and key player in drug development and oral delivery technologies serving pharmaceutical, biotech, and consumer health industries. [See CDMO profile]

  • Ophtapharm (a Sentiss Company): Ophthalmic and otic products — solutions, suspensions, emulsions, ointments, and gels — FDA-approved facility. [See CDMO profile]

  • HIPRA: End-to-end internal capabilities from cell line development to commercial manufacturing. [See CDMO profile]

  • Cambrex: Expertise in custom organic synthesis and contract R&D for pharmaceutical and fine chemical industries. [See CDMO profile]

  • Cellex Cell Professionals: CGT CDMO Cell Manufacturing Plant and Collection Center for Starting Materials. [See CDMO profile]

  • Content Group: Tubilux Pharma: registered office; manufacturing facility. [See CDMO profile]

  • Darnytsia Kyiv: Combining advanced facilities, stringent quality control, and expert staff to deliver reliable, compliant, and innovative solutions for its clients. [See CDMO profile]

  • TRADICHEM INDUSTRIAL SERVICES: HIPERING® TECHNOLOGY - THE GATEWAY FOR LEAN MANUFACTURING. [See CDMO profile]

  • Ascendia Pharmaceutical Solutions: GMP-certified CDMO for advanced sterile and non-sterile pharmaceutical manufacturing, formulation development, and analytical testing. [See CDMO profile]

  • White Raven: Fill and finish site dedicated to GMP Formulation and the Aseptic filling of Sterile Liquid Injectables. [See CDMO profile]

  • Green Phoenix Labs GmbH: Cell therapy company offering additional cleanroom capacity for advanced therapy manufacturing. [See CDMO profile]

  • Bilthoven Biologicals Drug Substance and Drug Product Facilities: Multi-product GMP facilities for drug substance and drug product manufacturing. [See CDMO profile]

  • Seda Pharma Development Services: Specialised in integrated pharmaceutical development and clinical pharmacology to support efficient development of optimal medicinal products, from conventional to complex formulations, leveraging strong scientific expertise. [See CDMO profile]

  • Glatt Pharmaceutical Services GmbH Co. & KG: cGMP-compliant CDMO providing end-to-end services for complex oral solid dosage forms. [See CDMO profile]

Related Information

  • Leading CDMO Companies in Belgium
  • Leading CDMO Companies in France
  • Leading CDMO Companies in Germany
  • Leading CDMO Companies in Ireland
  • Leading CDMO Companies in Italy
  • Leading CDMO Companies in Netherlands
  • Leading CDMO Companies in Portugal
  • Leading CDMO Companies in Spain
  • Leading CDMO Companies in Switzerland
  • Leading CDMO Companies in the UK
  • Leading CDMO Companies in Poland
  • Let MAI CDMO Network Help You Find the Right European CDMO Partner

    Choosing the right CDMO is a critical step in your pharmaceutical journey. By partnering with a European organization, you gain access to world-class expertise, robust regulatory support, and an unwavering commitment to quality. Whether you’re a startup or an established company, European CDMOs provide the tools and support you need to succeed.

    Let us help you find the perfect CDMO partner in Europe. Contact us today to explore tailored solutions for your pharmaceutical projects.